Inventor · disambiguated record
Joseph P. Lyssikatos
Also filed as: LYSSIKATOS JOSEPH · LYSSIKATOS JOSEPH P · LYSSIKATOS JOSEPH PETER
139 granted patents·56 pending applications·1,428 citations·filing 1997–2025
99Inventor score
Top patents by PatentIndex Score
195 records- 0197US11111235B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·7 cites·26 claims
- 0297US9815850B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·36 cites·41 claims
- 0397US6586447B13,3-disubstituted-oxindole derivatives useful as anticancer agentsPFIZER·Filed 2000·Granted Jul 1, 2003·77 cites·21 claims
- 0496US9932325B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Apr 3, 2018·16 cites·30 claims
- 0596US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 0696US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 0796US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0896US7425637B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2005·Granted Sep 16, 2008·27 cites·1 claims
- 0995US9440976B21,7-diazacarbazoles and methods of useGENENTECH INC·Filed 2015·Granted Sep 13, 2016·10 cites·5 claims
- 1095US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 1195US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 1294US7777050B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 17, 2010·13 cites·9 claims
- 1393US11427577B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2021·Granted Aug 30, 2022·2 cites·9 claims
- 1493US10780073B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2018·Granted Sep 22, 2020·7 cites·24 claims
- 1593US7235537B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Jun 26, 2007·53 cites·10 claims
- 1692US10961237B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Mar 30, 2021·4 cites·6 claims
- 1792US10076581B2Deuterated compounds and uses thereofGENENTECH INC·Filed 2016·Granted Sep 18, 2018·11 cites·15 claims
- 1892US9212186B2Bicyclic pyrazole LRRK2 small molecule inhibitorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·11 cites·18 claims
- 1992US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 2091US10081619B2Biaryl inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·7 cites·4 claims
- 2191US9809577B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2014·Granted Nov 7, 2017·12 cites·2 claims
- 2291US9693989B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesARRAY BIOPHARMA INC·Filed 2013·Granted Jul 4, 2017·13 cites·28 claims
- 2391US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 2491US7538120B2Method of treating inflammatory diseasesARRAY BIOPHARMA INC·Filed 2005·Granted May 26, 2009·11 cites·9 claims
- 2591US7019147B1Benzimidazole derivatives useful as antiproliferative agentsPFIZER·Filed 2000·Granted Mar 28, 2006·47 cites·20 claims
- 2691US6071935ADerivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitorsPFIZER·Filed 1997·Granted Jun 6, 2000·106 cites·26 claims
- 2790US11807638B25- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinasesENLIVEN INC·Filed 2022·Granted Nov 7, 2023·1 cites·44 claims
- 2890US11591316B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·1 cites·20 claims
- 2990US11504440B2Deuterated compoundsGENENTECH INC·Filed 2020·Granted Nov 22, 2022·2 cites·17 claims
- 3090US10759783B2Biaryl inhibitors of Bruton'S tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Sep 1, 2020·3 cites·11 claims
- 3190US10590114B2Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·5 cites·27 claims
- 3290US10227341B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Mar 12, 2019·8 cites·26 claims
- 3390US9676791B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2012·Granted Jun 13, 2017·5 cites·9 claims
- 3490US8648087B2N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseasesLYSSIKATOS JOSEPH P·Filed 2006·Granted Feb 11, 2014·24 cites·37 claims
- 3590US7491829B2RAF inhibitor compounds and methodsARRAY BIOPHARMA INC·Filed 2006·Granted Feb 17, 2009·17 cites·49 claims
- 3689US10675367B2Deuterated compounds and uses thereofGENENTECH INC·Filed 2018·Granted Jun 9, 2020·3 cites·7 claims
- 3789US10189829B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·6 cites·8 claims
- 3889US8461328B2Tricyclic heterocyclic compounds, compositions and methods of use thereofBABU SRINIVASAN·Filed 2011·Granted Jun 11, 2013·36 cites·18 claims
- 3989US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 4089US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 4189US7501427B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Mar 10, 2009·14 cites·37 claims
- 4289US7144907B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2003·Granted Dec 5, 2006·33 cites·34 claims
- 4389US2025034119A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4488US8163763B2Pyrimidine compounds, compositions and methods of useBERGERON PHILIPPE·Filed 2009·Granted Apr 24, 2012·28 cites·33 claims
- 4588US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 4688US7576114B2N3 alkylated benzimidazole derivatives as MEK inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Aug 18, 2009·5 cites·1 claims
- 4787US10028954B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2016·Granted Jul 24, 2018·4 cites·60 claims
- 4887US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 4987US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 5087US8637526B2Pyrazolopyrimidine JAK inhibitor compounds and methodsBLANEY JEFFREY·Filed 2011·Granted Jan 28, 2014·17 cites·18 claims
Showing the top 50 of 195 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →